BioSpace News Archive

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Armin Schon, Ph.D., has been appointed chief commercial officer, effective immediately.

Thermo Fisher Scientific, the world leader in serving science, today announced the Thermo Scientific Phenom Pharos G2 Desktop Field Emission Gun - Scanning Electron Microscope (FEG-SEM) designed to increase access to advanced nanomaterial research capabilities.

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, announced the future expansion of its biologics manufacturing capabilities through a lease agreement to occupy a former bakery in the Fremont-Wallingford neighborhood of Seattle.

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, recognizes the findings of a large retrospective observational analysis published in the Journal of Medical Economics.

Accure Health, a developer of rapid digital diagnostics, today announced the online publication of preliminary data showing that its novel saliva assay can assess individual immune response to COVID-19 vaccines, monitor neutralizing antibody levels over time, and model immune protection against SARS-Cov-2 variants.

Establishment Labs Holdings Inc. today announced the appointment of Ann Custin and Bryan Slotkin to its Board of Directors, effective immediately.

- Uncontrolled blood reflux leads to serious patient safety issues like thrombotic occlusions and infection - Only needleless connectors with bidirectional flow control - like Nexus TKO - can automatically prevent blood reflux, consistent with the 2021 INS Standards

Vivasure Medical today announced its development program for PerQseal ® Blue, the company’s new investigational product.

GentiBio, Inc. announced a strategic development and manufacturing partnership today to advance GentiBio’s unique immune tolerance platform.